However, since TRABID elicits certain pro-tumor functions such as proliferation and metastasis38–40, it might be an ideal target for not only inducing STING’s anti-tumor effects but neutralizing its pro-tumor effects on metastasis and proliferation, thereby achieving a better therapeutic outcome than STING agonists. Here, ZRANB1 is linked to neoplasm.